Expert Opinion on Drug Metabolism and Toxicology 2008-07-01

New emerging applications of molgramostim in acute myeloid leukaemia.

Xavier Thomas

Index: Expert Opin. Drug Metab. Toxicol. 4(6) , 795-806, (2008)

Full Text: HTML

Abstract

Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates the proliferation and differentiation of hematopoietic progenitor cells in the myeloid lineage, and plays a key role in host defence and the inflammatory process. The main schedules adopted for clinical applications of GM-CSF in acute myeloid leukaemia (AML) were post-chemotherapy, in order to shorten the duration of neutropenia, and as a mobilising agent to induce release of progenitor cells from bone marrow into circulation.

Related Compounds

  • MOLGRASTIM

Related Articles:

Study on the anti-H1N1 virus effects of quercetin and oseltamivir and their mechanism related to TLR7 pathway.

2012-01-01

[J. Asian Nat. Prod. Res. 14(9) , 877-85, (2012)]

Preoperative mobilization of bone marrow-derived cells followed by revascularization surgery: early and long-term outcome.

2012-01-01

[Int. J. Artif. Organs 35(1) , 67-76, (2012)]

Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.

2000-01-01

[Pflugers Arch. 440(5 Suppl) , R81-2, (2000)]

Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients.

2000-10-01

[Cytokine 12(10) , 1570-4, (2000)]

Locally applied molgramostim improves wound healing at colonic anastomoses in rats after ligation of the common bile duct.

2005-06-01

[Can. J. Surg. 48(3) , 213-8, (2005)]

More Articles...